SCHEMBL6972232

SCHEMBL6972232

Clc1ncnc2cc(OCCCC3CCNC3)cc(OC3CCOCC3)c12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 17/20 0.46
KDR P35968 13/20 0.46
EGFR P00533 5/20 0.46
LCK P06239 2/20 0.42
YES1 P07947 2/20 0.42
CSK P41240 2/20 0.42
FGFR1 P11362 1/20 0.42
AURKB Q96GD4 1/20 0.42
BMPR1B O00238 1/20 0.40
GAK O14976 1/20 0.40
EPHB6 O15197 1/20 0.40
RIPK2 O43353 1/20 0.40
STK10 O94804 1/20 0.40
MAP4K4 O95819 1/20 0.40
ABL1 P00519 1/20 0.40
FYN P06241 1/20 0.40
LYN P07948 1/20 0.40
RET P07949 1/20 0.40
HCK P08631 1/20 0.40
PDGFRB P09619 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3192319 0.84 SRC (0.53) SRCKDREGFRLCKYES1
SCHEMBL3205210 0.83 EGFR (0.53) SRCKDREGFRLCKYES1
SCHEMBL6970862 0.80 SRC (0.47) SRCKDREGFRLCKYES1
SCHEMBL3274564 0.80 SRC (0.47) SRCKDREGFRLCKYES1
SCHEMBL4022457 0.79 SRC (0.68) SRCKDREGFRLCKYES1
SCHEMBL3283169 0.78 SRC (0.64) SRCKDREGFRLCKYES1
SCHEMBL6613274 0.78 EGFR (0.70) SRCKDREGFR
SCHEMBL3274956 0.77 SRC (0.64) SRCKDREGFRLCKYES1
SCHEMBL3275626 0.77 SRC (0.68) SRCKDREGFRLCKYES1
SCHEMBL1012776 0.77 EGFR (0.62) SRCKDREGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001094341-A9 QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF TUMOURS ASTRAZENECA AB (SE) 2003-04-17 WO disclosed
EP-1292594-A1 QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF TUMOURS AstraZeneca AB (SE) 2003-03-19 EP disclosed
WO-2001094341-A1 QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF TUMOURS ASTRAZENECA AB (SE) 2001-12-13 WO disclosed